Curis shares are on the run again. This time it’s due to a secondary offering.
Curis has announced preliminary data from its ongoing early-stage study in patients with acute myeloid leukemia or high-risk myelodysplastic syndromes.
Friday's top analyst upgrades and downgrades included Advanced Micro Devices, Cloudflare, Dell Technologies, Lending Tree, Netflix, Tractor Supply, Twilio and Under Armour.
Curis shares jumped on Wednesday after the company announced a critical update from the FDA.
For the past 14 years, Germanwatch, an independent development and environmental organization that advocates for sustainable development, has ranked countries by their exposure and vulnerability to...
Curis shares jumped when the firm announced that it entered into an agreement to sell rights to a portion of royalty revenues on worldwide net sales of Erivedge.
Bio-Path shares are on a rampage, with its second day of more than doubling. Shares actually were halted at multiple points during the day for volatility spikes. This is all coming after the firm...
Bio-Path shares made an incredible run on Wednesday after the company announced interim results from its mid-stage leukemia trial.
The top analyst upgrades, downgrades and other research calls on Tuesday included Akamai Technologies, JetBlue Airways, Nordstrom, Nvidia, On Semiconductor, Southwest Airlines and Ventas.
Amazon has entered the pay-per-view business beginning with a UFC fight this Saturday. Should the cable and satellite companies be worried?
The top analyst upgrades, downgrades and other research calls from Thursday include Alkermes, ArQule, Bluebird Bio, Cognizant Technology Solutions, Ecolab, KLA-Tencor, Pandora Media, Verisk Analytics...
Merck, Omega Health, Cardinal Health, and Curis all posted new 52-week lows Monday.
Tuesday’s top analyst upgrades, downgrades and initiations include Amphenol, Finish Line, Jack Henry, Kite Pharmaceutical and Ultra Petroleum.
The top analyst upgrades, downgrades and initiations seen on Monday morning include BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto and Twenty-First Century Fox.